Clinical trial
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic…
NCT00186316 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186316 |
|---|---|
| Title | Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells |
| Official title | A Phase I/II Study of Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological |
| Interventions | Idiotype-pulsed allogeneic dendritic cells |
| Enrollment | 30 |
| Start date | Apr 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 25, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: